Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study

References

• Li L, Liu Y, Wu P, et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health. 2019;4(9):e473–ee81.
   PubMed Web of Science ®Google Scholar
• Hu S, Shi Q, Chen C-I, et al. Estimated public health impact of nationwide vaccination of infants with 7-valent pneumococcal conjugate vaccine (PCV7) in China. Int J Infect Dis. 2014;26:116–122.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang L, Xie M, et al. Recommendations for influenza SpViEPiCWG, Geriatric respiratory group, Geriatrics CSo. Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China. Aging Med. 2020;3(1):4–14.
   Google Scholar
• Modeling the economic burden of adult vaccine-preventable diseases in The United States. Health Aff. 2016;35(11):2124-2132.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Tang XF, Du CH, et al. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: a meta-analysis. Hum Vaccin Immunother. 2016 Dec;12(12):3056–3064.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cheng M, Wang S, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China. BMC Public Health. 2017;20(1):359.
   Web of Science ®Google Scholar
• Li X, Leng SX. Influenza immunization among Chinese seniors: urgent calling for improving vaccination coverage, education, and research. Aging Med. 2020;3(1):12–15.
   PubMedGoogle Scholar
• Zhang Y, Muscatello DJ, Wang Q, et al. Overview of influenza vaccination policy in Beijing, China: current status and future prospects. J Public Health Policy. 2017 Aug;38(3):366–379.
   PubMed Web of Science ®Google Scholar
• Yang J, Atkins KE, Feng L, et al. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016 Nov 11;34(47):5724–5735.
   PubMed Web of Science ®Google Scholar
• Yin M, Huang L, Zhang Y, et al. Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018 Jul;17(7):653–663.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2017 Evaluation of influenza vaccine effectiveness a guide to the design and interpretation of observational studies.
   Google Scholar
• Izurieta HS, Thadani N, Shay DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis. 2015 Mar;15(3):293–300.
   PubMed Web of Science ®Google Scholar
• Mahamat A, Daurès J-P, de Wzieres B. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study. Hum Vaccin Immunother. 2013;9(1):128–135.
   PubMed Web of Science ®Google Scholar
• Song JY, Lee JS, Wie SH, et al. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol: CVI. 2015 Feb;22(2):229–234.
   PubMed Web of Science ®Google Scholar
• Mues KE, Liede A, Liu J, et al. Use of the medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017;9:267.
   PubMed Web of Science ®Google Scholar
• Shi W, Ke C, Fang S, et al. Co-circulation and persistence of multiple A/H3N2 influenza variants in China. Emerg Microbes Infect. 2019;8(1):1157–1167.
   PubMed Web of Science ®Google Scholar
• Hainmueller J. Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies. Polit Anal. 2012;20(1):25–46. doi:10.1093/pan/mpr025.
   Web of Science ®Google Scholar
• Hainmueller J, Xu Y. Ebalance: a Stata Package for entropy balancing. J Stat Softw. 2013;54(7):18.
   Web of Science ®Google Scholar
• Phillippo DM, Ades AE, Dias S, et al. Methods for population-adjusted indirect comparisons in health technology appraisal. Med Decisi Mak: Int J Soc Med Decis Mak. 2018 Feb;38(2):200–211.
   PubMed Web of Science ®Google Scholar
• Brooks JM, Ohsfeldt RL. Squeezing the balloon: propensity scores and unmeasured covariate balance. Health Serv Res. 2013 Aug;48(4):1487–1507.
   PubMed Web of Science ®Google Scholar
• King G, Nielsen R. Why propensity scores should not be used for matching. Polit Anal. 2019;05/07(27):1–20.
   Google Scholar
• Zhao Q, Percival D. Entropy balancing is doubly robust. J Causal Inference. 2016;5(1):20160010. doi:10.1515/jci-2016-0010.
   Web of Science ®Google Scholar
• Wing C, Simon K, Bello-Gomez RA. Designing difference in difference studies: best practices for public health policy research. Annu Rev Public Health. 2018;39(1):453–469.
   PubMed Web of Science ®Google Scholar
• Zhou H, Taber C, Arcona S, et al. Difference-in-differences method in comparative effectiveness research: utility with unbalanced groups. Appl Health Econ Health Policy. 2016 Aug;14(4):419–429.
   PubMed Web of Science ®Google Scholar
• Dimick JB, Ryan AM. Methods for evaluating changes in health care policy: the difference-in-differences approach. JAMA. 2014;312(22):2401–2402.
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017 Aug 15;167(4):268–274.
   PubMed Web of Science ®Google Scholar
• Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2010 Nov 1;51(9):1007–1016.
   PubMed Web of Science ®Google Scholar
• Chang Y-C, Chou Y-J, Liu J-Y, et al. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan – a representative population-based comparative study. J Infect. 2012;65(3):231–238.
   PubMed Web of Science ®Google Scholar
• Hung IF-N, Tantawichien T, Tsai YH, et al. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013;17(6):e364–ee73.
   PubMed Web of Science ®Google Scholar
• Gostin LO, Salmon DA. The dual epidemics of COVID-19 and influenza: vaccine Acceptance, Coverage, and Mandates. JAMA. 2020;324(4):335–336. doi:10.1001/jama.2020.10802.
   Web of Science ®Google Scholar
• Nohynek H, Baum U, Syrjänen R, et al. Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16. Euro Surveill. 2016;21(38):30346.
   PubMedGoogle Scholar
• Simpson C, Lone N, Kavanagh K, et al. Seasonal influenza vaccine effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine. Health Services and Delivery Research. 2013;11/01(1):1–46.
   Google Scholar